Our guest on Episode 2 was Peter Holt, the CEO of The Joint Corp. The Joint is a $950 million market cap company that operates and franchises a chain of chiropractic offices. The company currently has over 600 total locations in about 35 states. Peter took the reigns as CEO of The Joint in 2016 and has overseen a stock that has appreciated from under $3 in 2016 to over $60 today. In fact, the company was distinctly unprofitable when Peter became CEO but has since started generating very healthy margins with limited capital expenditures. Given all of the recent success, I was excited to talk with Peter about:
- The demand drivers that have been propelling the company over the last five years;
- The elements that have allowed the stock to appreciate so rapidly in recent times;
- How he goes about making sure the company doesn’t grow too fast; and
- How Peter thinks about creating win-win relationships with franchisees
*For full disclosure, Cove Street is not a JYNT shareholder.
Please enjoy the show at the following sites:
Apple: https://podcasts.apple.com/us/podcast/creating-a-niche-global-franchise-with-peter-holt/id1579124518?i=1000544906891
YouTube: https://www.youtube.com/watch?v=HDbLLFUlqVQ
Podbean: https://compounders.podbean.com/e/creating-a-niche-global-franchise-with-peter-holt/
Spotify: https://open.spotify.com/episode/4bjYmAZ6WXY9sQFvHaXBeb
As always, if you have any comments, feedback, or guest recommendations, please contact us at podcast@covestreetcapital.com. You can also follow the podcast on Twitter @ https://twitter.com/CompoundersPod.
Incase you missed the last Compounders Podcast with Ben Gliklich, CEO of Element Solutions, Inc., you can view it here.
Compounders is sponsored by Tegus. With Tegus, you can learn everything you’d want to know about a company in an on-demand digital platform. Investors share their expert calls, allowing others to instantly access more than 25,000 calls on former Compounders guests such as Viasat, Element Solutions, Avid Technology—or almost any company of interest. All you have to do is log in. If you’re ready to go deeper on any company and you appreciate the value of primary research, head to tegus.co/compounders for a free trial.
